Hirose T - Search Results

1

Development of new basal insulin peglispro (LY2605541) ends in a disappointing result.

Hirose T. Hirose T. Diabetol Int. 2016 Jan 29;7(1):16-17. doi: 10.1007/s13340-016-0255-1. eCollection 2016 Mar. Diabetol Int. 2016. PMID: 30603238 Free PMC article. No abstract available.

2

Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptin monotherapy: a phase 3, multicenter, open-label, long-term study.

Hirose T, Saitoh C, Oikawa I, Kondo N. Hirose T, et al. Diabetol Int. 2018 Jan 12;9(3):168-178. doi: 10.1007/s13340-017-0341-z. eCollection 2018 Jul. Diabetol Int. 2018. PMID: 30603364 Free PMC article.

3

Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.

Yoshikawa F, Uchino H, Nagashima T, Usui S, Miyagi M, Ando Y, Hirose T. Yoshikawa F, et al. Among authors: hirose t. Diabetol Int. 2021 Jun 5;13(1):124-131. doi: 10.1007/s13340-021-00513-6. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059248 Free PMC article.

4

Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.

Yoshikawa F, Kumashiro N, Shigiyama F, Miyagi M, Ando Y, Uchino H, Hirose T. Yoshikawa F, et al. Among authors: hirose t. Diabetol Int. 2021 Jun 2;13(1):142-147. doi: 10.1007/s13340-021-00516-3. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059250 Free PMC article.

5

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.

Shigiyama F, Kumashiro N, Miyagi M, Ikehara K, Kanda E, Uchino H, Hirose T. Shigiyama F, et al. Among authors: hirose t. Cardiovasc Diabetol. 2017 Jul 6;16(1):84. doi: 10.1186/s12933-017-0564-0. Cardiovasc Diabetol. 2017. PMID: 28683796 Free PMC article. Clinical Trial.

6

Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study.

Shigiyama F, Kumashiro N, Fuchigami A, Hirose T. Shigiyama F, et al. Among authors: hirose t. Cardiovasc Diabetol. 2018 Jun 12;17(1):86. doi: 10.1186/s12933-018-0730-z. Cardiovasc Diabetol. 2018. PMID: 29895330 Free PMC article.

7

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).

Fuchigami A, Shigiyama F, Kitazawa T, Okada Y, Ichijo T, Higa M, Hiyoshi T, Inoue I, Iso K, Yoshii H, Hirose T, Kumashiro N. Fuchigami A, et al. Among authors: hirose t. Cardiovasc Diabetol. 2020 Jan 7;19(1):1. doi: 10.1186/s12933-019-0977-z. Cardiovasc Diabetol. 2020. PMID: 31910850 Free PMC article. Clinical Trial.

8

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.

Hiruma S, Shigiyama F, Hisatake S, Mizumura S, Shiraga N, Hori M, Ikeda T, Hirose T, Kumashiro N. Hiruma S, et al. Among authors: hirose t. Cardiovasc Diabetol. 2021 Feb 2;20(1):32. doi: 10.1186/s12933-021-01228-3. Cardiovasc Diabetol. 2021. PMID: 33530982 Free PMC article. Clinical Trial.

9

SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes.

Igarashi H, Uchino H, Kanaguchi M, Hisanaga K, Sato G, Yoshikawa F, Furuta M, Washizawa N, Usui S, Miyagi M, Hirose T. Igarashi H, et al. Among authors: hirose t. Diabetol Metab Syndr. 2023 Feb 19;15(1):25. doi: 10.1186/s13098-023-00990-6. Diabetol Metab Syndr. 2023. PMID: 36804863 Free PMC article.

10

Open-label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin-naïve Asian patients with type 2 diabetes.

Hirose T, Cai Z, Yeo KP, Imori M, Ohwaki K, Imaoka T. Hirose T, et al. J Diabetes Investig. 2018 Jan;9(1):100-107. doi: 10.1111/jdi.12667. Epub 2017 May 20. J Diabetes Investig. 2018. PMID: 28371567 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,678 results

Search Page